Abstract: In one embodiment, a method for information management comprises monitoring output from an application, wherein the output is monitored substantially continuously; determining if the output is associated with a predetermined type of version; and saving data associated with the output if the output is associated with the predetermined type of version.

Abstract: The present invention is directed to a method of inhibiting at least one of vascular leakage, inflammation and fibrosis in an animal by administering to the animal a vascular leakage inhibiting amount of a composition, wherein at a substantially higher amount the composition is effective in inhibiting angiogenesis, and wherein the anti-angiogenic activity of the composition is separate from the vascular leakage inhibiting activity of the composition. The animal experiencing at least one of vascular leakage, inflammation and fibrosis has a disease selected from the group consisting of diabetes, chronic inflammation, brain edema, arthritis, uvietis, macular edema, cancer, hyperglycemia, a kidney inflammatory disease, a disorder resulting in kidney fibrosis, a disorder of the kidney resulting in proteinuria, and combinations thereof.

Abstract: The present invention is directed to a method of inhibiting at least one of vascular leakage, inflammation and fibrosis in an animal by administering to the animal a vascular leakage inhibiting amount of a composition, wherein at a substantially higher amount the composition is effective in inhibiting angiogenesis, and wherein the anti-angiogenic activity of the composition is separate from the vascular leakage inhibiting activity of the composition. The animal experiencing at least one of vascular leakage, inflammation and fibrosis has a disease selected from the group consisting of diabetes, chronic inflammation, brain edema, arthritis, uvietis, macular edema, cancer, hyperglycemia, a kidney inflammatory disease, a disorder resulting in kidney fibrosis, a disorder of the kidney resulting in proteinuria, and combinations thereof.

Abstract: The present invention is directed to a method of inhibiting at least one of vascular leakage, angiogenesis, inflammation and fibrosis in an animal by administering to the animal an effective amount of a composition, wherein the composition is selected from the group consisting of kallistatin, fragments of kallistatin, analogs or derivatives of kallistatin, and combinations thereof.

Abstract: A method for forming microcellular foams that causes the material to expand uniaxially during the foaming process, and a method for forming objects from the foam. Liquid crystal polymers or polymers having a planar crystalline structure are saturated with a fluid, normally a gas such as carbon dioxide. The ambient conditions are changed such that the fluid is in a supersaturated state, and the material is brought to near its glass transition temperature to induce the formation of nonspherical elongated gas-filled cells. A process for making objects, such as transducer diaphragms, from microcellular foams includes the step of forming the objects prior to the foaming process.

Abstract: A vaginal drug delivery device includes a tubular base of an inert rubber composition, a first layer having a thickness up to 3 mm composed of a mixture of a drug to delivered, at least one surfactant and at least one dispersing agent applied to said outer surface of the tubular base, and a second layer of silicone rubber having a thickness up to 1 mm encapsulating the first layer on the tubular base whereby said drug will diffuse through said second layer when the device is inserted into the vagina to treat the patient with the drug in the first layer.

Abstract: An adaptive sequential controller (480) for controlling a single-phase circuit breaker, multiple circuit breakers in a multi-phase configuration, or a multi-phase circuit breaker to substantially eliminate transients upon closing the circuit breaker and to minimize switching energy when the circuit breaker for any phase of the line is open. The device adaptively compensates for changes in the response time of the circuit breaker due to aging and environmental affects. To control the circuit breaker so that is closes at a zero crossing of the voltage waveform, the adaptive sequential controller includes a potential transformer (70) that is connected to the distribution line. The potential transformer provides a reference signal corresponding to the zero crossing or zero instance of the voltage waveform. If the power factor of the load coupled to the line is known and remains relatively constant, a current transformer is not required.

Abstract: An adaptive sequential controller (50/50') for controlling a circuit breaker (52) or other switching device to substantially eliminate transients on a distribution line caused by closing and opening the circuit breaker. The device adaptively compensates for changes in the response time of the circuit breaker due to aging and environmental effects. A potential transformer (70) provides a reference signal corresponding to the zero crossing of the voltage waveform, and a phase shift comparator circuit (96) compares the reference signal to the time at which any transient was produced when the circuit breaker closed, producing a signal indicative of the adaptive adjustment that should be made. Similarly, in controlling the opening of the circuit breaker, a current transformer (88) provides a reference signal that is compared against the time at which any transient is detected when the circuit breaker last opened.